Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp.

LEXX | NASDAQ
Chart Builder DCF Calculator
$3.42
+$0.18 (+5.56%)
At close: Sep 21, 2026, 4:00 PM ET
$3.42
$0 (+0.15%)
After-hours: Sep 21, 2026, 4:10 PM ET

Market Data

Market Cap
$5.66M
Enterprise Value
$2.13M
Beta
0.34
Average Volume
26.08K
Shares Outstanding (Diluted)
1.65M
Shares Change YoY
35.56%
Institutional Ownership
6.10%
Exchange
NASDAQ
ISIN
US52886N6040

Price Performance

Price Change 1M
-68.8%
Price Change 3M
-59.8%
Price Change 6M
-70.6%
Price Change YTD
-65.1%
Price Change 1Y
-83.1%
Price Change 3Y
-75.5%
Price Change 5Y
-96.7%
1M CAGR (ann.)
-34.9%
1Y CAGR (ann.)
-81.3%
5Y CAGR (ann.)
-48.0%
All-Time CAGR
-40.7%

Valuation

PE Ratio
-0.64
Forward PE
N/A
PEG Ratio
-0.01
Forward PEG
0.07
PS Ratio
29.17
Forward PS
4.00
PB Ratio
1.19
P/FCF Ratio
-0.75
P/Adj. FCF Ratio
-0.72
P/OCF Ratio
-0.76
EV/Sales
10.98
EV/EBIT
-0.28
EV/EBITDA
-0.28
EV/FCF
-0.28
Earnings Yield
-155.6%
FCF Yield
-132.5%
Adj. FCF Yield
-139.0%

Financial Health

Net Cash
$3.62M
Total Debt
$86.71K
Cash & Short-Term Investments
$3.62M
Total Assets
$4.78M
Current Ratio
10.60
Quick Ratio
10.60
Debt / Equity Ratio
0.02
Debt / EBITDA
-0.01
Debt / FCF
-0.01
OCF / Debt
-85.63
Interest Coverage
0.00
Altman Z-Score
-16.66
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-3973.2%
EBITDA Margin
-3958.1%
Net Profit Margin
-3985.6%
FCF Margin
-3866.6%
Adj. FCF Margin
-4054.9%
SBC / Revenue
188.4%
SBC Impact (per share)
-4.9%

Returns

Return on Assets
-161.7%
Return on Equity
-160.7%
Return on Invested Capital
-174.0%
Return on Capital Employed
-175.3%
Return on Tangible Assets
-174.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
-14.2%
Revenue CAGR 5Y
-25.1%
Revenue CAGR 10Y
18.1%
EPS CAGR 3Y
8.6%
EPS CAGR 5Y
28.4%
EPS CAGR 10Y
13.3%
FCF CAGR 3Y
-17.7%
FCF CAGR 5Y
-14.4%
FCF CAGR 10Y
-16.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
2
EPS Growth Next 3Y
159.3%
Revenue Growth Next 3Y
612.5%
Earnings Date
Oct 27, 2026
EPS Estimate (next Q)
-$0.90
EPS Growth Est (next Q)
-57.1%
Revenue Est (next Q)
$50K
Revenue Growth Est (next Q)
-75.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$1.50
Price Target Upside
-56.1%

Cash Flow

Operating Cash Flow
$-7.43M
Free Cash Flow
$-7.5M
Adj. Free Cash Flow
$-7.87M
FCF Per Share
-$4.55
OCF Per Share
-$4.49
OCF/S Ratio
-3827.6%

Income Statement

Revenue
$194K
Gross Profit
$194K
Operating Income
$-7.71M
EBITDA
$-7.68M
Net Income
$-7.73M
EPS (Diluted)
-$5.32
Revenue / Employee
$27.71K
Profit / Employee
$-1.1M
Employees
7

© 2026 bestshares.com. All rights reserved.